Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug

摘要

BackgroundNanotechnology-based drug delivery approaches may help increase therapeutic efficacy and decrease side effects of chemotherapeutics. We investigated expression levels of folate receptor (FR) in squamous cell carcinoma of the head and neck (SCCHN) to evaluate FR as a target for nanotherapy.